Skip to main content
. 2022 Jul 14;6(5):775–780. doi: 10.1016/j.jseint.2022.06.006

Table I.

Patient demographics/comorbidities for patients with and without chronic steroid use. Bold P-values indicate statistical significance with P < .05.

Characteristic Non steroid
Chronic steroid
P value
Number Percent Number Percent
Total 25,376 100.0 1293 100.0
Age .133
 18-39 121 0.5 23 1.8
 40-64 6978 27.5 357 27.6
 65-74 10,591 41.7 552 42.7
 ≥75 7686 30.3 361 27.9
Body mass index (kg/m2) .188
 <18.5 174 0.7 22 1.7
 18.5-29.9 12,057 47.5 670 51.8
 30-34.9 6806 26.8 311 24.1
 35-39.9 3638 14.3 158 12.2
 ≥40 2701 10.6 132 10.2
Gender <.001
 Female 13,975 55.1 879 68.0
 Male 11,401 44.9 414 32.0
Functional status prior to surgery <.001
 Independent 24,859 98.0 1242 96.1
 Dependent 517 2.0 51 3.9
ASA classification <.001
 1-2 10,982 43.3 315 24.4
 ≥3 14,394 56.7 978 75.6
Smoker .546
 No 22,757 89.7 1153 89.2
 Yes 2619 10.3 140 10.8
Diabetes mellitus .234
 No diabetes 20,777 81.9 1071 82.8
 Non-insulin dependent 3281 12.9 148 11.4
 Insulin dependent 1318 5.2 74 5.7
Hypertension .334
 No 8525 33.6 417 32.3
 Yes 16,851 66.4 876 67.7
COPD <.001
 No 23,769 93.7 1126 87.1
 Yes 1607 6.3 167 12.9
Bleeding disorders <.001
 No 24,768 97.6 1230 95.1
 Yes 608 2.4 63 4.9
Open wound/wound infection <.001
 No 25,295 99.7 1278 98.8
 Yes 81 0.3 15 1.2
Disseminated cancer <.001
 No 25,328 99.8 1279 98.9
 Yes 48 0.2 14 1.1
Acute renal failure .449
 No 25,365 100.0 1292 99.9
 Yes 11 0.0 1 0.1

ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease.